FCPA Compliance and Ethics Report-Episode 136, Joel Borgquist, President of Etik
MacEwen: Law Firm M&A Demands 'Cultural Due Diligence'
Compliance Training for Employees: Trends in GRC
Private Equity Fees and Expenses
Ethics Laws and the Importance of Transparency for Public Officials
The Sunshine Act: Putting It into Practice – Interview with Karen Lovitch, Member, Mintz Levin
Weekly Brief: 78% of Law Schools Ignore ABA Rule
With the June 30 deadline for Phase 2 Sunshine Act reports by pharmaceutical and medical device manufacturers (“Applicable Manufacturers”) and group purchasing organizations (“GPOs’) quickly approaching, the Centers for...more
CMS will begin to enforce what could be significant penalties on manufacturers who fail to report required data.
The Centers for Medicare & Medicaid Services (CMS) has announced a short timeframe before detailed...more
In This Issue:
- Third Circuit Panel Liberalizes “Protected Activity” Immunity for Employees Claiming Whistleblower Status
- Doing Time: A Requirement for White Collar Crime?
- Casting a Smaller Net:...more
The Centers for Medicare & Medicaid Services (“CMS”) recently launched the National Physician Payment Transparency Program: OPEN PAYMENTS website, which provides Sunshine Act compliance resources, including Fact Sheets and...more
Reports on Physician Ownership and Investment Interests
The Sunshine Act requires applicable manufacturers, as well as applicable GPOs, to report to the Secretary, in electronic form, certain information concerning...more
Report Submission and Review
Pre-Submission Review is Not Required
Applicable manufacturers may voluntarily provide covered recipients the opportunity to review the data prior to submission to CMS, but doing so is not...more
Public disclosure of payments from pharmaceutical, medical device, biologic, and medical supply manufacturers to physicians and hospitals will begin under a final rule on the Physician Payments Sunshine Act (Sunshine Act)...more
Back to Top